HSBC TUR.WAR.OP.END. ABL/ DE000TT8X1N0 /
2024-05-02 8:28:46 AM | Chg.0.0000 | Bid8:42:58 AM | Ask8:42:58 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.4100EUR | 0.00% | 0.4100 Bid Size: 15,000 |
0.4200 Ask Size: 15,000 |
Abbott Laboratories | 150.0568 USD | 2078-12-31 | Put |
GlobeNewswire
03-25
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
GlobeNewswire
03-15
Attention Reckitt Benckiser Group investors: Portnoy Law Firm Announces Investigation into Reckitt B...
GlobeNewswire
2023-11-14
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports In...
GlobeNewswire
2023-10-19
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer
GlobeNewswire
2023-10-10
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
GlobeNewswire
2023-10-02
Apnimed Adds Independent Director Paul Fonteyne, MS, MBA to Board of Directors
GlobeNewswire
2023-09-06
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region